OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 2,550 results

Filters: clofazimine

Identification of novel mutations associated with clofazimine resistance in Mycobacterium abscessus
Chen, Y.; Chen, J.; Zhang, S.; Zhang, W.; Zhang, W.; Zhu, M.; Zhang, Y.
biorxiv. 2018-03-04. Preprint
Source:biorxiv
PPRID: 10.1101/276022v1 doi:10.1128/aac.00544-18
Evaluation of effectiveness of clofazimine therapy. I. Monitoring of absorption of clofazimine from gastrointestinal tract.
A Mathur, K Venkatesan, V P Bharadwaj, G Ramu
Indian J Lepr. 1985 Jan-Mar.57(1):146-8 Print
Source:PubMed
PMID: 3839813 doi:
Clofazimine binding studies with deoxyribonucleic acid.
N E Morrison, G M Marley
Int J Lepr Other Mycobact Dis. 1976 Oct-Dec.44(4):475-81 Print
Source:PubMed
PMID: 798729 doi:
Safety and tolerability of clofazimine as salvage therapy for atypical mycobacterial infection in solid organ transplant recipients.
P F Cariello, E J Kwak, R C Abdel-Massih, F P Silveira
Transpl Infect Dis. Feb, 2015.17(1):111-8 Print-Electronic
Source:PubMed
PMID: 25620390 doi:10.1111/tid.12340
A case of clofazimine enteropathy.
A Hameed, F X Beach, R H Kennedy, R E Barry
Int J Clin Pract. Sep, 1998.52(6):439-40 Print
Source:PubMed
PMID: 9894387 doi:
Impacts of clofazimine on the treatment outcomes of drug-resistant tuberculosis.
Ming-Gui Wang, Xiang-Min Liu, Shou-Quan Wu, Jian-Qing He
Microbes Infect. 2023 Jan-Feb.25(1-2):105020 Print-Electronic
Source:PubMed
PMID: 35792202 doi:10.1016/j.micinf.2022.105020
[Tissue distribution and deposition of clofazimine in mice following oral administration of isoniazid].
Yu Lu, Mei-Qin Zheng, Bin Wang, Wei-Jie Zhao, Lei Fu, Peng Li, Bo-Wen Liang, Nai-Hui Chu
Zhonghua Jie He He Hu Xi Za Zhi. Sep, 2009.32(9):694-7 Print
Source:PubMed
PMID: 20079285 doi:
Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice.
H Saito, K Sato
Tubercle. Sep, 1989.70(3):201-5 Print
Source:PubMed
PMID: 2559522 doi:10.1016/0041-3879(89)90051-2
Clofazimine: new products. Major antileprous drug.
No authors listed
Prescrire Int. Apr, 1999.8(40):44-6 Print
Source:PubMed
PMID: 10848059 doi:
Quantifying the Reversibility of Clofazimine-induced Pigmentation in a Patient with Mycobacterium abscessus Pulmonary Disease.
Masashi Ito, Fumiya Watanabe, Koji Furuuchi, Keiji Fujiwara, Tatsuya Kodama, Takashi Ohe, Yoshiaki Tanaka, Takashi Yoshiyama, Ken Ohta, Kozo Morimoto
Intern Med. Nov 21, 2024.: Print-Electronic
Source:PubMed
PMID: 39566985 doi:10.2169/internalmedicine.4498-24
0